Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
50%(1 trials)

Phase Distribution

Ph phase_2
1
25%
Ph phase_3
2
50%
Ph phase_4
1
25%

Phase Distribution

0

Early Stage

1

Mid Stage

3

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
Phase 3Large-scale testing
2(50.0%)
Phase 4Post-market surveillance
1(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(2)
Terminated(1)
Other(1)

Detailed Status

Completed2
Withdrawn1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (25.0%)
Phase 32 (50.0%)
Phase 41 (25.0%)

Trials by Status

completed250%
withdrawn125%
unknown125%

Recent Activity

0 active trials
Showing 4 of 4
withdrawnphase_3

Pediatric High-Risk Deep Venous Thrombosis Lytic Outcomes Trial

NCT02767232
completedphase_3

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

NCT00790335
completedphase_2

Intraventricular Rt-PA in Patients With Intraventricular Hemorrhage

NCT00029315
unknownphase_4

Low Dose Rt-PA for Acute Normotensive Pulmonary Embolism With RVD

NCT01531829

Clinical Trials (4)

Showing 4 of 4 trials
NCT02767232Phase 3

Pediatric High-Risk Deep Venous Thrombosis Lytic Outcomes Trial

Withdrawn
NCT00790335Phase 3

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Completed
NCT00029315Phase 2

Intraventricular Rt-PA in Patients With Intraventricular Hemorrhage

Completed
NCT01531829Phase 4

Low Dose Rt-PA for Acute Normotensive Pulmonary Embolism With RVD

Unknown

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4